Development Plan for a combined tissue-engineered product (ATMP)

The Project

Small biotech company (SME) developing an allogenic tissue-engineered product (TEP) for the treatment of heart failure that lacked the internal expertise for early-stage drug development plan.

The Challenge

The Challenge

Define an overall drug development plan at an early stage:

  • Regulatory strategy and recommended activities
  • Define milestones for manufacturing, nonclinical, clinical development
  • Time points for interaction with competent authorities (national and EMA)
  • Timelines
  • Cost (including fees and possible external support)
The Solution

The Solution

Client benefitted from Biopharma Excellence brain tank i.e., extensive ATMP, CMC and Strategy  experience.

  • Biopharma Excellence strategic expert provides development plan including:
    • Early development up to MAA
    • Timelines and costs
    • Advice on do‘s and don’ts
  • F-2-F-meeting to illustrate key elements and provision of further details
  • Supported client with experts for ATMP, Strategy, CMC, Nonclinical and Clinical Strategy
The Outcome

The Outcome

Reliable development plan for strategic decisions covering early development up to MAA.

  • Received reliable estimates for resources and timelines to achieve a central MA in a highly innovative field
  • Basis for strategic decision of Company’s management
  • Basis for Company’s management for budget negotiations with Investors
  • Regulatory support right from the start involving a strong partner that is able to support all steps from drug development to MA, and beyond

Start a conversation today


    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more